Trastuzumab; efficacité et tolérance dans le cancer du sein (étude rétrospective de 2 cas)
| dc.contributor.advisor | Y. Cherrah | |
| dc.contributor.author | Assya Mardas | |
| dc.date.accessioned | 2023-09-15T13:37:46Z | |
| dc.date.accessioned | 2026-01-22T13:32:02Z | |
| dc.date.available | 2023-09-15T13:37:46Z | |
| dc.date.issued | 2011 | |
| dc.description.collaborator | Y. Cherrah | |
| dc.description.collaborator | A. Errihani | |
| dc.description.collaborator | H. Hachi | |
| dc.description.collaborator | J. Lamsaouri | |
| dc.identifier.uri | https://toubkal.imist.ma/handle/123456789/18624 | |
| dc.identifier.uri | https://doi.org/10.83129/toubkal-13762 | |
| dc.language.iso | fr | |
| dc.publisher | Université Mohammed 5 de Rabat, Faculté de Médecine et de Pharmacie, Rabat | fr_FR |
| dc.subject | Trastuzumab | fr_FR |
| dc.subject | cancer du sein | fr_FR |
| dc.subject | HER2 | fr_FR |
| dc.subject | efficacité | fr_FR |
| dc.subject | toxicité | fr_FR |
| dc.subject.other | Sciences médicales | |
| dc.subject.specific | Oncologie | |
| dc.title | Trastuzumab; efficacité et tolérance dans le cancer du sein (étude rétrospective de 2 cas) | fr_FR |
Files
Original bundle
1 - 1 of 1